EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 11/22/2009 1:00 PM EST

Researchers Identify Role of Gene in Tumor Development

Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis

View

Rare Pancreatic Cancer Patients May Live Longer When Treated with Radiation Therapy

Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

View

FISH Technology Preferred for Choosing HER-2-Positive Breast Cancer Treatments

The debate on how to select patients who will respond best to costly drug treatments for aggressive breast cancer now favors fluorescence in situ hybridization (FISH) to measure the HER-2 receptor found in human breast tumors, according to a leading pathologist presenting at the Association for Molecular Pathology annual meeting.

View

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 11/23/2009 12:05 AM EST

CP24 Partners with PMHF for ‘One Day’ to Change Face of Breast Cancer Diagnosis in Canada

CP24 has joined forces with The Princess Margaret Hospital Foundation (PMHF) to help raise awareness for the ‘One Day’ breast cancer rapid diagnosis campaign. All day on Thursday, November 19, CP24 will broadcast from Princess Margaret Hospital featuring interviews with doctors and patients about one-day breast cancer diagnosis. The goal is to help secure the funding to help expand the program in order to diagnose more women and men.

View

New Markers of Prognosis for Cancer Therapies Highlighted

As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Lewis Cantley will moderate a press conference on “Markers of Prognosis in Cancer Treatment” on Wednesday, Nov. 18, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET.

View

Researchers Create 'Fly Paper' to Capture Circulating Cancer Cells

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for examining and diagnosing cancer metastasis, determining patient prognosis, and monitoring the effectiveness of therapies.

View

Media Coverage of New Mammography Guidelines Confusing to Some, Says Expert

The public may have problems this week sorting through news articles about a government task force’s opposition to routine mammograms for women under 50 and articles about breast cancer survivors touting the benefits of early mammograms. But to properly interpret the news, the public must learn to balance the research with the anecdotal evidence says UAB Associate Professor of English Cynthia Ryan, Ph.D.

View

Common Pain Relief Medication May Encourage Cancer Growth

Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies show that shielding cancer cells from opiates reduces proliferation, invasion and migration.

View